During the past decade, Scripps Health conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 3 clinical trials were completed, i.e. on average, 21.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Scripps Health" #1 sponsor was "Scripps Translational Science Institute" with 7 trials, followed by "Provista Diagnostics, Inc" with 2 trials sponsored, "Biosense Webster, Inc." with 1 trials sponsored, "Celularity Incorporated" with 1 trials sponsored and "Hybrigenics Corporation" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Scripps Health" #1 collaborator was "Affymetrix, Inc." with 1 trials as a collaborator, "Baxter Healthcare Corporation" with 1 trials as a collaborator, "Baylor Scott and White Health" with 1 trials as a collaborator, "California Institute for Regenerative Medicine (CIRM)" with 1 trials as a collaborator and "Columbia University" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Scripps Health" are "Breast Cancer" (2 trials), "Heart Failure" (2 trials), "ARDS" (1 trials), "Acne Vulgaris" (1 trials) and "Acute Myelogenous Leukemia" (1 trials). Many other conditions were trialed in "Scripps Health" in a lesser frequency.

Most popular intervention types in "Scripps Health" are "Device" (5 trials), "Drug" (2 trials), "Procedure" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ablation and skin resurfacing" (1 trials), "Bortezomib" (1 trials), "CGM Only" (1 trials), "CGM+BGM" (1 trials) and "CYNK-001" (1 trials). Other intervention names were less common.

The vast majority of trials in "Scripps Health" are 17 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Scripps Health". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Scripps Health, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Scripps Health, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".